Characterization of the structure and membrane interaction of the antimicrobial peptides aurein 2.2 and 2.3 from Australian southern bell frogs

Biophysical Journal

Volumn 92, Issue 8, 2007, Pages 2854-2864

  Pan, Yeang Ling ^a   Cheng, John T J ^a   Hale, John ^a   Pan, Jinhe ^a   Hancock, Robert E W ^a   Straus, Suzana K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMYRISTOYL SN GLYCERO 3 PHOSPHOCHOLINE; 1,2 DIMYRISTOYL SN GLYCERO 3 [PHOSPHO RAC(1GLYCEROL)]; AUREIN; LIPID; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ALPHA HELIX; ANTIMICROBIAL ACTIVITY; ARTICLE; BILAYER MEMBRANE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; DRUG SYNTHESIS; FROG; LITORIA AUREA; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

LITORIA AUREA; LITORIA RANIFORMIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 34147135478     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.097238     Document Type: Article

References (68)

1. Hancock, R. E. W. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1:156-164.
2. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature. 415:389-395.
3. Hancock, R. E. W. 2005. Mechanisms of action of newer antibiotics for Gram-positive pathogens. Lancet Infect. Dis. 5:209-218.
4. Devine, D. A., and R. E. W. Hancock. 2002. Cationic peptides: distribution and mechanisms of resistance. Curr. Pharm. Des. 8:703-714.
5. Peschel, A., and H. G. Sahl. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
6. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta. 1462:55-70.
7. Papo, N., and Y. Shai. 2005. Host defense peptides as new weapons in cancer treatment. Cell. Mol. Life Sci. 62:784-790.
8. Matsuzaki, K. 1999. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta. 1462:1-10.
9. Yang, L., T. M. Weiss, R. I. Lehrer, and H. W. Huang. 2000. Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys. J. 79:2002-2009.
10. Huang, H. W. 2000. Action of antimicrobial peptides: two-state model. Biochemistry. 39:8347-8352.
11. Mecke, A., D. K. Lee, A. Ramamoorthy, B. G. Orr, and M. M. Holl. 2005. Synthetic and natural polycationic polymer nanoparticles interact selectively with fluid-phase domains of DMPC lipid bilayers. Langmuir. 21:8588-8590.
12. Mecke, A., D. K. Lee, A. Ramamoorthy, B. G. Orr, and M. M. Banaszak Holl. 2005. Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. Biophys. J. 89:4043-4050.
13. Chen, F. Y., M. T. Lee, and H. W. Huang. 2003. Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation. Biophys. J. 84:3751-3758.
14. Wu, M., E. Maier, R. Benz, and R. E. W. Hancock. 1999. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry. 38:7235-7242.
15. Hancock, R. E. W., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
16. Bechinger, B., and K. Lohner. 2006. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim. Biophys. Acta. 1758:1529-1539.
17. Straus, S. K., and R. E. Hancock. 2006. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta. 1758:1215-1223.
18. Pukala, T. L., J. H. Bowie, V. M. Maselli, I. F. Musgrave, and M. J. Tyler. 2006. Host-defence peptides from the glandular secretions of amphibians: structure and activity. Nat. Prod. Rep. 23:368-393.
19. Rinaldi, A. C. 2002. Antimicrobial peptides from amphibian skin: an expanding scenario. Curr. Opin. Chem. Biol. 6:799-804.
20. Giovannini, M. G., L. Poulter, B. W. Gibson, and D. H. Williams. 1987. Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones. Biochem. J. 243:113-120.
21. Zasloff, M. 1987. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA. 84:5449-5453.
22. Zasloff, M., B. Martin, and H. C. Chen. 1988. Antimicrobial activity of synthetic magainin peptides and several analogues. Proc. Natl. Acad. Sci. USA. 85:910-913.
23. 31P solid-state NMR spectroscopy study. Biochim. Biophys. Acta. 1712:101-108.
24. Bechinger, B., M. Zasloff, and S. J. Opella. 1993. Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy. Protein Sci. 2:2077-2084.
25. Duclohier, H., G. Molle, and G. Spach. 1989. Antimicrobial peptide magainin I from Xenopus skin forms anion-permeable channels in planar lipid bilayers. Biophys. J. 56:1017-1021.
26. Hallock, K. J., D. K. Lee, and A. Ramamoorthy. 2003. MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. Biophys. J. 84:3052-3060.
27. Jacob, L., and M. Zasloff. 1994. Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. Ciba Found. Symp. 186:197-216.
28. Ramamoorthy, A., S. Thennarasu, D. K. Lee, A. Tan, and L. Maloy. 2006. Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin. Biophys. J. 91:206-216.
29. Ambroggio, E. E., F. Separovic, J. Bowie, and G. D. Fidelio. 2004. Surface behaviour and peptide-lipid interactions of the antibiotic peptides. Maculatin and citropin. Biochim. Biophys. Acta. 1664:31-37.
30. Ambroggio, E. E., F. Separovic, J. H. Bowie, G. D. Fidelio, and L. A. Bagatolli. 2005. Direct visualization of membrane leakage induced by the antibiotic peptides: maculatin, citropin, and aurein. Biophys. J. 89:1874-1881.
31. Balla, M. S., J. H. Bowie, and F. Separovic. 2004. Solid-state NMR study of antimicrobial peptides from Australian frogs in phospholipid membranes. Eur. Biophys. J. 33:109-116.
32. Boland, M. P., and F. Separovic. 2006. Membrane interactions of antimicrobial peptides from Australian tree frogs. Biochim. Biophys. Acta. 1758:1178-1183.
33. Marcotte, I., K. L. Wegener, Y. H. Lam, B. C. Chia, M. R. de Planque, J. H. Bowie, M. Auger, and F. Separovic. 2003. Interaction of antimicrobial peptides from Australian amphibians with lipid membranes. Chem. Phys. Lipids. 122:107-120.
34. Niidome, T., K. Kobayashi, H. Arakawa, T. Hatakeyama, and H. Aoyagi. 2004. Structure-activity relationship of an antibacterial peptide, maculatin 1.1, from the skin glands of the tree frog, Litoria genimaculata. J. Pept. Sci. 10:414-422.
35. Chen, T., L. Li, M. Zhou, P. Rao, B. Walker, and C. Shaw. 2006. Amphibian skin peptides and their corresponding cDNAs from single lyophilized secretion samples: identification of novel brevinins from three species of Chinese frogs. Peptides. 27:42-48.
36. Conlon, J. M., N. Al-Ghaferi, B. Abraham, H. Jiansheng, P. Cosette, J. Leprince, T. Jouenne, and H. Vaudry. 2006. Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. Peptides. 27:2111-2117.
37. Kumari, V. K., and R. Nagaraj. 2001. Structure-function studies on the amphibian peptide brevinin 1E: translocating the cationic segment from the C-terminal end to a central position favors selective antibacterial activity. J. Pept. Res. 58:433-441.
38. Morikawa, N., K. Hagiwara, and T. Nakajima. 1992. Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa. Biochem. Biophys. Res. Commun. 189:184-190.
39. Simmaco, M., G. Mignogna, D. Barra, and F. Bossa. 1993. Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta. FEBS Lett. 324:159-161.
40. Won, H. S., S. S. Kim, S. J. Jung, W. S. Son, B. Lee, and B. J. Lee. 2004. Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea. Mol. Cells. 17:469-476.
41. Rozek, T., K. L. Wegener, J. H. Bowie, I. N. Olver, J. A. Carver, J. C. Wallace, and M. J. Tyler. 2000. The antibiotic and anticancer active aurein peptides from the Australian bell frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2. Eur. J. Biochem. 267:5330-5341.
42. Li, X., Y. Li, A. Peterkofsky, and G. Wang. 2006. NMR studies of aurein 1.2 analogs. Biochim. Biophys. Acta. 1758:1203-1214.
43. Rozek, T., J. H. Bowie, J. C. Wallace, and M. J. Tyler. 2000. The antibiotic and anticancer active aurein peptides from the Australian bell frogs Litoria aurea and Litoria raniformis. Part 2. Sequence determination using electrospray mass spectrometry. Rapid Commun. Mass Spectrom. 14:2002-2011.
44. Apponyi, M. A., T. L. Pukala, C. S. Brinkworth, V. M. Maselli, J. H. Bowie, M. J. Tyler, G. W. Booker, J. C. Wallace, J. A. Carver, F. Separovic, and others. 2004. Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance. Peptides. 25:1035-1054.
45. Wang, G., Y. Li, and X. Li. 2005. Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor. J. Biol. Chem. 280:5803-5811.
46. 1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 113:967-974.
47. Hwang, T. L., and A. J. Shaka. 1995. Water suppression that works: excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. Ser. A. 112:275-279.
48. Sinha, N., C. V. Grant, C. H. Wu, A. A. De Angelis, S. C. Howell, and S. J. Opella. 2005. SPINAL modulated decoupling in high field double-and triple-resonance solid-state NMR experiments on stationary samples. J. Magn. Reson. 177:197-202.
49. Wu, M., and R. E. Hancock. 1999. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J. Biol. Chem. 274:29-35.
50. Perham, M., J. Liao, and P. Wittung-Stafshede. 2006. Differential effects of alcohols on conformational switchovers in alpha-helical and beta-sheet protein models. Biochemistry. 45:7740-7749.
51. Wishart, D. S., C. G. Bigam, A. Holm, R. S. Hodges, and B. D. Sykes. 1995. 1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J. Biomol. NMR. 5:67-81.
52. Chen, F. Y., M. T. Lee, and H. W. Huang. 2002. Sigmoidal concentration dependence of antimicrobial peptide activities: a case study on alamethicin. Biophys. J. 82:908-914.
53. Wu, Y., H. W. Huang, and G. A. Olah. 1990. Method of oriented circular dichroism. Biophys. J. 57:797-806.
54. de Jongh, H. H., E. Goormaghtigh, and J. A. Killian. 1994. Analysis of circular dichroism spectra of oriented protein-lipid complexes: toward a general application. Biochemistry. 33:14521-14528.
55. Tremouilhac, P., E. Strandberg, P. Wadhwani, and A. S. Ulrich. 2006. Synergistic transmembrane alignment of the antimicrobial heterodimer PGLa/magainin 2. J. Biol. Chem. 281:32089-32094.
56. Kucerka, N., M. A. Kiselev, and P. Balgavy. 2004. Determination of bilayer thickness and lipid surface area in unilamellar dimyristoylphosphatidylcholine vesicles from small-angle neutron scattering curves: a comparison of evaluation methods. Eur. Biophys. J. 33:328-334.
57. Dathe, M., H. Nikolenko, J. Meyer, M. Beyermann, and M. Bienert. 2001. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett. 501:146-150.
58. Hallock, K. J., D. K. Lee, J. Omnaas, H. I. Mosberg, and A. Ramamoorthy. 2002. Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. Biophys. J. 83:1004-1013.
59. Mani, R., J. J. Buffy, A. J. Waring, R. I. Lehrer, and M. Hong. 2004. Solid-state NMR investigation of the selective disruption of lipid membranes by protegrin-1. Biochemistry. 43:13839-13848.
60. Henzler Wildman, K. A., D. K. Lee, and A. Ramamoorthy. 2003. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry. 42:6545-6558.
61. 31P solid-state NMR, and differential scanning calorimetry studies. Biophys. J. 89:2434-2442.
62. Falla, T. J., and R. E. Hancock. 1997. Improved activity of a synthetic indolicidin analog. Antimicrob. Agents Chemother. 41:771-775.
63. Zasloff, M. 2002. Antimicrobial peptides in health and disease. N. Engl. J. Med. 347:1199-1200.
64. Porcelli, F., B. A. Buck-Koehntop, S. Thennarasu, A. Ramamoorthy, and G. Veglia. 2006. Structures of the dimeric and monomeric variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR spectroscopy. Biochemistry. 45:5793-5799.
65. Wu, Y., K. He, S. J. Ludtke, and H. W. Huang. 1995. X-ray diffraction study of lipid bilayer membranes interacting with amphiphilic helical peptides: diphytanoyl phosphatidylcholine with alamethicin at low concentrations. Biophys. J. 68:2361-2369.
66. 31P solid-state NMR spectroscopy investigation. Biochemistry. 39:13106-13114.
67. Matsuzaki, K., O. Murase, N. Fujii, and K. Miyajima. 1996. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry. 35:11361-11368.
68. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.